"What if the dreamboat outperforms the Medtone C in lowering A1C? Does this invalidate the previous testing results, requiring further trials?"

While some might view the FDA as not only adverse, but perverse, I sure hope the above is just some sort of conditioned response to investing in biotech! I can't come up with persuasive reasoning that would allow such a result, but, then again, I'm sure the FDA can (or Shrekli, however you spell that devils name).